about
On the promise of pharmacotherapies targeted at cognitive and neurodegenerative components of Down syndromeThe effect of pharmacological and non-pharmacological interventions for epilepsy in people with Down syndromeThe functional nature of synaptic circuitry is altered in area CA3 of the hippocampus in a mouse model of Down's syndromeNeurological phenotypes for Down syndrome across the life spanPathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: A view from preclinical studiesCharacterization of PTZ-induced seizure susceptibility in a down syndrome mouse model that overexpresses CSTBSoy-based diet exacerbates seizures in mouse models of neurological diseaseAlzheimer's disease and Down syndrome rodent models exhibit audiogenic seizures.Sudden unexpected death in people with down syndrome and epilepsy: another piece in this complicated puzzleModulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives.Recent advances in the genetics of epilepsy: insights from human and animal studies.Health conditions associated with aging and end of life of adults with Down syndromeSpecific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice.Understanding mental retardation in Down's syndrome using trisomy 16 mouse models.Treatment strategies for myoclonic seizures and epilepsy syndromes with myoclonic seizures.Autism spectrum disorder and epilepsy: Disorders with a shared biology.Genetic and biologic classification of infantile spasms.The somatic comorbidity of epilepsy: a weighty but often unrecognized burden.What's hAPPening at synapses? The role of amyloid β-protein precursor and β-amyloid in neurological disorders.Down syndrome: Cognitive and behavioral functioning across the lifespan.Neonatal and Infantile Epilepsy: Acquired and Genetic Models.The GIRK2 subunit is involved in IS-like seizures induced by GABA(B) receptor agonists.Myoclonic epilepsy of late onset in trisomy 21.Meeting the challenge of epilepsy in persons with multiple handicaps.Prenatal etiologies of West syndrome.Spectrum of epilepsy in terminal 1p36 deletion syndrome.Altered distribution of hippocampal interneurons in the murine Down Syndrome model Ts65Dn.Clinical and EEG features of epilepsy in children and adolescents in Down syndrome.An assessment of optokinetic nystagmus (OKN) in persons with Down syndrome.Epilepsy in children with Down syndrome: not so benign as generally accepted.Age, sex and mental retardation related changes of brainstem auditory evoked potentials in Down's syndrome.Early clinical and EEG features of infantile spasms in Down syndrome.Seizures in Alzheimer's disease: clinicopathologic study.
P2860
Q22241936-B001B308-E50E-48A0-BC3E-FD2452BC825DQ24200869-5A694B9B-BEB2-4975-AAEF-D8523E31EEA2Q24679420-92F6E16D-2322-404D-84B6-5350CD81759EQ27025698-6F51C42A-447A-4209-B19A-7914CBC2C1E8Q27308052-A9D1910E-BB9E-442F-8AC2-CECAF5571653Q28478194-E9232868-D3CD-4F74-B20F-7F66719C2E49Q30445118-D478B48F-37C1-44F6-BC05-55981A1B269BQ30477832-E95B1E57-B712-4F0B-877E-D48C8603A27FQ33351862-A5A48DA5-B6B8-4C82-B423-36E4266809CAQ33659830-3546209B-2B88-4EE0-83B1-4692AF669790Q33755692-C057711E-A4EB-4E54-85CE-75561498226FQ34440144-6FD0D1B2-59EF-43CB-A35A-24D4864EDBB1Q35177041-0CD11582-5F64-4F59-90B7-6E2B1549D51DQ35204307-7F0FC0CC-35FB-41B5-B1D4-2F12C3DC4025Q35594589-7EDBC424-2F48-4323-B58B-7977C75CFDBEQ35762766-6EE943FB-388A-47FC-AF7F-F086CED95521Q37960573-731937F4-504F-4275-B5C8-B38E5415EE52Q38018125-59DB1896-71C7-4CA1-B7C6-29031A969819Q38038399-E38758D3-E6EF-413E-B589-A477D55FA4ECQ38491559-34CD5D7B-6781-40AF-8173-256AC41955C9Q38659279-24226778-4BD5-4B93-8DDF-C6F161ED63D1Q40880509-B66C4C14-1D22-4098-87E2-941E6BEC0469Q41054361-CA607EF4-2A26-4319-9977-F41381A4506CQ41681434-1B92695C-6695-45E8-958D-9154B45CC154Q48258394-2E22D6F5-B6DD-4AA6-A2E3-12083B4ADB3AQ48450753-DB57032B-5930-4241-B4A2-9BD02F77CE66Q48455685-63888D52-C888-461F-9DDC-10C5B98BF249Q48678560-2A5935F5-0F3D-4BAF-9DBF-23D8FBD368D4Q48948944-185816B2-D38A-4811-B104-D0771997002DQ50561906-C57D07EF-CDF0-4448-A8A4-D22D11DB1916Q51033664-E812539E-A34D-40DD-B14B-59F19DC7DF1EQ51561967-D0398C26-E7F6-4C5B-B3A8-21728D5F9CD1Q53203295-7B9769D3-131A-46E9-8543-3AAE5C4526DE
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Seizure disorders in Down syndrome.
@en
Seizure disorders in Down syndrome.
@nl
type
label
Seizure disorders in Down syndrome.
@en
Seizure disorders in Down syndrome.
@nl
prefLabel
Seizure disorders in Down syndrome.
@en
Seizure disorders in Down syndrome.
@nl
P2093
P1433
P1476
Seizure disorders in Down syndrome.
@en
P2093
P304
P356
10.1001/ARCHNEUR.1991.00530150088024
P577
1991-03-01T00:00:00Z